M3UVTM STEADY-STATE* IRRADIATION ©
WORLD MAXIMUM MICROBE KILL-POWER *Photon Capacitance
Site In Construction
MolecuCare ®, Inc.
…Living better for less
Thank you
Disinfection R&D, Consultants and Equipment
Builders
Consultant to: Government, Industry, Corporate America, Foreign
Ministries and Military, Healthcare, etc.
All equipments manufactured in the U.S.A. in our facility
We Do Not Promote Client
Engineering, Architectural, Environmental, Hydrological
special interests note our equipment procedure; inquiries invited from your
arena
This site includes temporary advisory (below)
by the FDA for those recent passengers that may have been on a flight carrying
an Extensive Drug Resistant Tuberculosis patient and is copied here for public
view – including this article on our site
does not imply a product sponsorship by the FDA. - Chairman, MolecuCare, Inc.
Every airliner in the daily sky creating ‘AIRLINER EFFECT’ is a bio-culture, and proof of the same inadequacy of the hospital ‘HEPA’ filtration central system failure to remove the pathogen, and without any exception of microbe type or threat.
Re-storing health once Tuberculosis (a lesser airborne illness), is contracted can mean months to years of recovery care treatment, and in some cases, Intensive Isolation.
Airlines place all passengers (and crew) at risk unnecessarily as airships can be equipped with air-cleaning measures that would remove this threat and unwarranted alarm, and apprehension for all that has become so much a part of air travel.
‘Indoor’ Air Health
Steady-State Pure POWER to reduce illness and
your health costs
product technologies for commercial use
CMIAE acquisition development program*
Healthy
air for the airline passenger
AIRcaire ™
AIRFRAME
Safe Air Generator© Airframe System
AIRcaire ……..the
safest breathing on or off the planet ©
New, Tested, Evolutionary Essential passenger need,
developed by Molecucare
17 years in
development
Airlines: (For your passengers, your service, your vision)
you deserve a healthy trip with
MolecuCare® technology aboard
Installed by the
airframe manufacturer: look for our
AIRcaire™
The
safest breathing on or off the planet ©
™
Seal on your ticket, ship or ship’s literature
AIRcaire™
REMOVES airborne infectious
CONDITION: Infectious indoor airborne microorganisms are contagious to
anyone sharing that air. When the air is captured as it is in the airship cabin
with high concentration of a few hundred occupants, everything pathogenic in
that air will be sampled by all within minutes. An
infectious airborne illness irradiation technology has been developed to defend
the airliner passenger. It is new, safe and reliable, and represents world
impact change important to world health.
AIRcaire™ is unprecedented care for your air
health. AIRcaire™ REMOVES
THIS CONDITION:
“AIRLINER EFFECT”
Present airliner air movement is hundreds of cubic feet per minute volume-exposure
risk increasing with the size of the airship.
Viruses, the most contagious and deadly infectious pathogens, are a
challenge to remove from fast-moving air. Any airborne disease with emergency
consequence, e.g., SARS, Avian Flu and Ebola, have a free reign of infectious
event exaggerated when dozens to hundreds of people breathe the same air
repeatedly – the airliner condition. The standard defense technology that is
known as the HEPA filter, cannot, and will not prevent virus passage or
resultant airborne infectious transmittance from one individual to the other.
This passage of the virus through filters is clearly demonstrated every day in
the drug industry as virus contaminate occurs regularly spoiling production
lots, in spite of the finest filtration used. Pointedly, where the mainstay air
cleaning method in the hospital is the HEPA filter, this institutional
infectious zone is globally prominent. Every
airliner in the sky creating AIRLINER EFFECT is a prodigious culture proof of
the inadequacy of HEPA filtration applied biologically, Drug industry filters
are too dense to have been used for any breathing apparatus. Other product technology on this planet
cannot kill airborne bacteria, virus and mold spores at a rate needed for
measurable indoor air correction and health in that airliner condition.
Air disinfection equipment killS
all microbe cellular life and particularly, the virus known to readily pass
through a HEPA filter. Any BIO-threat is minimized if the ship itself is
equipped with this technology, and it can be. This is a key defense logistic of
immeasurable value to the airship passenger and will grow in meaning as
critical as is world air traffic safety itself.
We invite your attention to our sites related to airflight
health:
www.indoorairhealth.com www.avianfluairdisinfection.com www.molecucare.com
PAR™
6300
Portable Safe Air Generator ©Emergency Equipment
6000 cfm @ 80 Joules/ft3/sec ‘Roll-In’ Portable
Safe-Air Quarantine Zone Generator©
Portable
Air Remedy is an essential stand-by high volume
air disinfection emergency tool for any community, building complex, airport
promenade or special feature quarters, or corporate campus, and the new concept
in air correction needed in pandemic (SARS, AVIAN FLU, etc.) emergency
management. When either large patient numbers spill over from hospital space,
and when other emergency air quality bio-threat occurs. For use anywhere where
a problem of airborne bio-threat has become or may become a present risk (such
as in Flu, Tuberculosis, SARS, etc.) or there is evidence when exposure to
contracted illnesses of a congestive origin has occurred, is suspect or known
and spread is indeterminate.
IS YOUR AIRPORT
PREPARED FOR EMERGENCY AIRBORNE CONTAGIOUS ILLNESS? Gathering a large group in closed–in space
where each person represents separate exposures in world travel, is a violent
health liability today to those captured, and to family and associates later.
There being no definition of the passengers infected prior to, during or after
flight exposure, there is no means to measure the extent today of in-flight
illness contraction. But the myriad of illness reporting tells the story plain
enough, that flight time is a health risk.
WORLDWIDE PANDEMIC
SITUATION CREATED BY INTERNATIONAL AIRLINE
TRAVEL: LACK
OF ABILITY TO DETERMINE INDIVIDUAL
ILLNESS OR HEALTH CONDITION IDENTITY - adds to any attempt at
crowd-quarantine mentioned by risk management agencies looking at airline
disease contraction as a very serious worldwide vector problem in a pandemic
situation.
There is no way to avoid
accidental mixing of those that may be infected during the flight and the
healthy unaffected by that flight. Unfortunately, little now is available for
stand-by readiness as a defense protocol. There can be no concerns at mixing
possible ill with the healthy as there will be little indication of the
difference in a crowd collection, so early in the disease evidence, with little
exception. Few understand today that when post-flight participants are gathered
(ad hoc collected in unprotected rooms instead of in air protected
space), there is a very high threat to their health – a serious threat that may
exceed the flight time duration, as passengers may be constrained thereafter in
an emergency due to evolving events.
PAR™ CHANGES THIS RISK as A DEFENSE METHOD FOR THE HEALTHY and
reduced challenge to the ill. ‘Quarantine’ of the healthy with the ill, is a fatal strategy
without extreme air defense protection used in the ‘made-available’ quarantine
area.
These portable (wheeled) units are now available
as an airport quarantine stand-by defense. Quarantine space can be properly
out-fitted with air correction by these roll-in heavy duty air volume
displacement (6,000+ CFM) as the defense method overriding ‘sick’ air existing
in that space.
This defense method is new to airport
management, or other jurisdictional control defense preparation, for use as an
advanced caution effort.
When the building is not equipped with MolecuCare
HVADC:
The Pro-Active Engagement with Prognostic Air Quality
You can
do something about airborne
emergency:
6,000 cfm @
60 Joules/ft3/sec Safe-Air Generator©
10 ‘8” L X
34” W X 49” H
Rubber Tired
Swivel Wheeled Cushioned Chassis App. 600 lbs.
-
PAR™ air
quality zone correction increases the opportunity for the healthy survival when
mixed with the ill.
-
-
PAR™ Portable Air
Remedy is a critical logistic defense
(prevention spread) method. It is an essential tool: stand-by high
volume air disinfection emergency air blanketing for triage event space. It
will be needed for emerging pandemic threat to any community, building complex,
airport or corporate campus.
-
-
PAR™, Stand-By wherever there might be a crowd exposure
or similar to street or building accident or purposeful event having created a
problem of airborne contagion bio-threat. As a meaningful defense protection in
the absence of other airborne defense equipment or facility. Such
public event may be local or building oriented may be the source of
event, or for those spaces used as
defense zones for larger victim counts, for enlarged emergency care
spaces.
-
-
PAR™, in CONSTRUCTION: the routine safety provision for
construction personnel during building alterations and remediation mold
removal, a common event. Mold removal failure has resulted in building
abandonment, closure and condemnation. Construction professionals agree that
‘mold-chasing’ is a serious challenge to the building personnel as well as
workers. Mold removal failure evidence in later building use is avoided with
follow-up installation with the full-time building equipped AIRcaire™ product.
PAR: 6,000 cfm @ 80Joules/ft3/sec
Roll-In Safe-Air Disinfection Safety zone preparation logistic: www.avianfluairdisinfection.com
\AQUAIRE ™
Water Conservation and Purity
SHIPBOARD
WATER
Inboard water processing
or safe
foreign sourcing with our H2O-Vault high volume cost effective disinfection Safe
water generator© products
Engineering
Air and Water Health, Products by MolecuCare®, Inc.
Licensor to the OEm, product service and equipment to
all
H2O-VAULT ©
Water Conservation and Purity; Safe Water Generator©
-
The rugged compact water machine for microbe clean-up
of every bio contaminant, newly designed and executed for long term operation,
a minimum of access maintenance, and, service that does not require special
tools or skills. Stunning is the capacity – large enough to service the
skyscraper building and building complex, the gated community and the community
itself. Several features of this design using the MolecuCare disinfection power
have changed the cost and care for water bio correction permitting owner
control of water qualities and safety. Structure avoiding contact between flow
and metal materials permits unusual application and life expectancy including
lifetime performance consistency and dependability. This technology product
delivered in a machine critical to community or building health at any time is
adaptable to vaulted separation, unique security features important in a world
beleaguered with destructive intent.
www.H2O-VAULT.com www.waterrecovery.com
* CMIAE Program (see www.molecucare.com)
Airframe test model (five identical Generator units each phase)
preliminary work study project: Phase I prototype configuration suitable for
designated airship bio-test worthiness to performance criteria,
non-environmental engineering unit; Phase II advanced prototype configuration
and environmental structural integrity to performance criteria; Phase III final
model production prototype for certification use to performance criteria
Project lift-off costs to vendor expense adjustments for project
maintenance dependent upon locations of project elements and dimension.
Reference
Library of Health by MolecuCare:
AIR: 1 800 966 9853 WATER: 1 800 242 5883
www.MolecuCare.com
Made in the U.S.A.
Copyright ® MolecuCare®, Inc.
2007, New Milford, CT 06776
(ABOVE) Excerpt from MolecuCare Reference Library: Journal
Watch, New England Journal Of medicine, April 15, 2007, pp 66 Vol 27 No.8
We invite
all to review this factual article study of airflight illness (above).
Noteworthy is the result that seven disease types infected 43% of 67
people. Since there are literally hundreds
of diseases, you might ponder mathematically what the chances are of finding
43% of one group with such similarity of illness. Missing data worthy of such a study: what were the common flights
to these people.
|
|
|
|
This is an official CDC
Health Advisory Distributed via Health Alert Network December 29, 2007, 19:35
EST (07:35 PM EST) CDCHAN-00267-07-12-29-ADV-N Investigation of
International Traveler with Multidrug-Resistant Tuberculosis (MDR TB) The Centers for Disease Control and Prevention (CDC) is
working with international, state, and local health officials and other
partners on an investigation involving an international traveler to the U.S.
who had recently been diagnosed with multidrug-resistant tuberculosis (MDR
TB). CDC was informed in mid-December 2007 by a local health
authority that a patient who had been diagnosed in India with MDR TB traveled
from New Delhi, India to Chicago, Illinois on December 13, 2007 on American
Airlines Flight # 293 and then on a shorter
flight within the United States. Shortly after final arrival, the patient
sought treatment for hemoptysis, fever, and chest pain at a hospital. These
and other findings indicated a potential for transmission of drug-resistant
TB infection to others. The patient has been hospitalized in airborne isolation and is receiving
treatment for TB. Shortly after being notified about the patient and her
travels, officials of CDC’s Division of Global Migration and Quarantine
contacted American Airlines and U.S. Customs and Border Protection to obtain
the information needed to contact passengers who may have been exposed to the
traveler with tuberculosis. CDC is collaborating with U.S. state and local
health departments, the Indian Ministry of Family Welfare, American Airlines,
and the Department of Homeland Security’s Customs and Border Protection to
ensure notification and follow-up of passengers and crew who may have been
exposed to MDR TB. In accordance with the World Health Organization (WHO)
TB and Airline Travel Guidelines, CDC is ensuring appropriate follow-up and
care for persons who may have been exposed to TB on an aircraft. This
includes recommending the evaluation and testing of passengers and crew with
closest contact to the patient on board American Airlines Flight #293
departing from New Delhi, India on December 13, 2007 and arriving in Chicago,
Illinois on December 13, 2007. This includes 44 passengers. These were the
passengers seated in the same row as the index patient (row 35), and those
seated in the two rows ahead (rows 33 and 34) and the two rows behind (rows
36 and 37), as well as the crew members working in the same cabin. These
persons should receive an initial evaluation and testing for TB infection,
with follow-up 8 to 10 weeks after the December 13 flight for re-evaluation. CDC recommends testing of these passengers and crew on
only the international flight from New Delhi to Chicago because this flight
was longer than the 8 hour duration criteria specified by WHO for passenger
testing for exposure to tuberculosis. WHO and CDC do not recommend
notification or medical evaluation of passengers on briefer flights because
the risk of transmission is minimal. WHO guidelines can be found at http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.363_eng.pdf CDC issued an Epi-X notification on December 28, 2007
to health officials in 17 states based on locating information provided by 42
of the 44 potentially exposed passengers. (Locating information was not
available on two passengers). These states include California, Colorado,
Florida, Georgia, Illinois, Indiana, Kansas, Michigan, Minnesota, Missouri,
New Jersey, North Carolina, Ohio, Tennessee, Texas, Vermont, and Virginia.
These states should inform CDC’s Division of Global Migration and
Quarantine’s duty officer if they are unable to contact any of the passengers
with destinations in their states. The duty officer can be reached by calling
CDC’s Director’s Emergency Operation Center (DEOC) at (770) 488-7100. Drug-susceptible (regular) TB and MDR TB are thought to
be spread the same way. The risk of acquiring any type of
TB appears to depend on several factors, such as extent of disease
in the source patient, duration of exposure, and ventilation. TB
bacilli become aerosolized when a person with TB disease of the lungs or
throat coughs, sneezes, speaks, or sings. These bacilli can float in the air
for several hours, depending on the environment. Persons who breathe
air containing these TB bacilli can become infected. Transmission
has been documented in association with patients who have TB lung
disease, and bacteria seen or cultured in sputum. Persons who become
infected usually have been exposed for several hours (or days) in poorly
ventilated or crowded environments. An important way to prevent the spread
and transmission is by limiting an infectious person’s contact with
other people. Thus, people who have suspected or confirmed TB or MDR TB
that is potentially infectious should be placed on treatment and
kept isolated until they are no longer infectious. State and local health departments who want additional
information may contact CDC’s Division of Global Migration and Quarantine’s
duty officer through the CDC Director’s Emergency Operation Center (DEOC) at
(770) 488-7100. Persons who believe they may have been exposed to TB or
MDR TB, or their clinicians, can call 1-800 CDC INFO for further information. Where to go for information about: Tuberculosis: http://www.cdc.gov/tb/default.htm MDR TB: http://www.cdc.gov/tb/pubs/tbfactsheets/mdrtb.htm http://www.cdc.gov/tb/pubs/tbfactsheets/drugresistanttreatment.htm
Infection control: http://www.cdc.gov/tb/pubs/tbfactsheets/ichcs.htm and http://www.cdc.gov/tb/pubs/tbfactsheets/rphcs.htm Tuberculosis and Air Travel: http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.363_eng.pdf ____________________________________________________________________________________ Categories of Health Alert messages: Health Alert conveys the highest
level of importance; warrants immediate action or attention. Health Advisory
provides important information for a specific incident or situation; may not
require immediate action. Health Update provides
updated information regarding an incident or situation; unlikely to require
immediate action. ## This Message was distributed to State and Local Health Officers,
Epidemiologists, State Laboratory Directors, PHEP Coordinators, HAN
Coordinators and Public Information Officers as well as Public Health
Associations and Clinician organizations
## The CDC and
HHS logos are the exclusive property of the Department of Health and Human
Services and may not be used for any purpose without prior express written
permission. Use of trade names and commercial sources is for identification
only and does not imply endorsement by the U.S. Department of Health and
Human Services. Links to
non-Federal organizations are provided solely as a service to our users.
Links do not constitute an endorsement of any organization by CDC or the
Federal Government, and none should be inferred. The CDC is not responsible
for the content of the individual organizations. Please
send us your feedback or comments: http://www.cdc.gov/flu/coca/feedback.htm. Our
Clinician Communication Team is committed to excellence in reporting our
weekly updates. Please e-mail coca@cdc.gov
should you note any written errors or discrepancies.
|
|||||||
(BELOW)
NIH ADVISORY:
|
|
|
|
Web Letter for PassengersXDR TB in Traveler
Return to Extensively Drug-Resistant Tuberculosis (XDR
TB) Dear Passenger or Flight Crew Member: A person with extensively drug-resistant tuberculosis (XDR TB) traveled on an airline flight you may have taken in May 2007:
Tuberculosis (TB) is a disease caused by germs that are spread from person to person through the air. TB and XDR TB are spread the same way, but XDR TB is resistant to almost all of the drugs commonly used to treat TB disease. The general symptoms of TB disease include cough, weight loss, fever, and night sweats. When a person with TB disease of the lungs or throat coughs, sneezes, or speaks, TB germs may be expelled into the air and can remain airborne for several hours, depending on the environment. Persons who breathe the air containing these TB germs can become infected; this is called latent TB infection (LTBI). This is the first investigation of a case of XDR TB during air travel. Due to the serious nature of this strain of TB disease, CDC is recommending that all U.S. residents and citizens on either of these flights receive evaluation and testing for TB infection. Passengers who were most at risk were those sitting two rows in front and two rows behind the patient. If you were a passenger or flight crew member on either of the two flights listed above, we strongly recommend that you complete these steps at your earliest convenience: 1. See your physician or local health department and request TB testing. Bring documentation of travel history for the flight and health history with you. 2. Receive TB testing, which should include an evaluation of signs and symptoms of TB, a TB skin test or the QuantiFERON®TB Gold blood test (QFT-G) to test for TB infection, and possibly a chest x-ray. 3. If needed, return to your healthcare provider for a second TB test 8–10 weeks following your flight date (i.e., the time of your last possible exposure to the patient). 4. Keep a copy of your test results for your records. If you ever experience any signs or symptoms of TB disease in the future (regardless of your test result), see a physician promptly and explain that you were possibly exposed to a person with XDR TB. Many persons born outside of the United States receive a
vaccine called
BCG (Bacille-Calmette Guerin) For inquiries related to this investigation or questions
regarding payment for TB testing, please go to
State TB Control Offices. For more information about XDR TB, please see these links: ·
Get the Facts About TB Disease ·
What you Need to Know About the TB Skin Test ·
Protect your Family and Friends from TB ·
Extensively Drug-Resistant Tuberculosis (XDR TB) We greatly appreciate your assistance on this important international XDR TB contact investigation.
|
||||||||||||
|
|
You will need Adobe Acrobat™ Reader v5.0 or higher to read
pages that are in PDF format.
Download the Adobe Acrobat™ Reader If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available. Division of
Tuberculosis Elimination cdcinfo@cdc.gov Home Site Map Contact Us Accessibility Privacy Policy Notice FOIA USA.gov CDC Home Search Health Topics A-Z
Centers for Disease Control & Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention Division of Tuberculosis Elimination CDCINFO@cdc.gov |
The
following is an excerpt from the NIH bulletin 
|
|
Who
should be tested?
(Copied
from NIH bulletin as follows)
The World Health Organization has guidelines for follow-up and care of persons who may have been exposed to someone with TB during air travel. In accordance with these guidelines, CDC recommends that all U.S. citizens and residents who were passengers or crew on these flights be evaluated and tested for TB infection.
The following persons are the highest priority for evaluation:
- Passengers seated in rows 28-32 on Air France # 385/Delta # 8517, departing Atlanta May 12th; arriving in Paris May 13th
- Passengers seated in rows 10-14 on Czech Air # 0104, departing from Prague and arriving in Montreal May 24th
- Flight crew members working in the same cabin on each of the flights listed above
Why
is CDC not following up with passengers who were on the shorter flights with
the XDR TB patient?
Both CDC and the World Health Organization (WHO) consider the risk of infection to travelers on flights under eight hours to be very low. However, if you were a passenger on one of the flights that were shorter than 8 hours and are concerned, check with your local public health department or your primary care physician about being tested for TB.
Can
a person who was on the same flight with the XDR TB patient give TB to others?
Only a person with active TB disease can transmit TB germs to others. If you have been around someone with TB disease (or XDR TB disease), you can get TB infection. However, not everyone infected with TB germs becomes sick. As a result, two TB-related conditions exist: latent TB infection and active TB disease. A person with latent TB infection cannot spread germs to other people, but can develop active TB disease in the future. People with medical conditions or on medications that suppress the immune system are at higher risk to become ill with active TB disease.
Am
I at risk for exposure if I took the same flight the following day as the XDR
TB patient, or was in the same boarding area?
Persons who become infected usually have been exposed for several hours (or days) in poorly ventilated or crowded environments. Boarding the same plane the next day or being in the same boarding area would not warrant evaluation. TB is not spread through countertops, chairs, doorknobs, or other surfaces where a TB patient has been.
However, if travelers are concerned about exposure, check with your state or local health department or your primary care provider about being tested for TB.
AABBAirlinerAirColorJune82007